Literature DB >> 16905883

Relationship of stimulation site location within the subthalamic nucleus region to clinical effects on parkinsonian symptoms.

Tetsuo Yokoyama1, Naoto Ando, Kenji Sugiyama, Soichi Akamine, Hiroki Namba.   

Abstract

OBJECTIVE: To determine the relationship of the stimulation site in the subthalamic region to the clinical effects on parkinsonian symptoms, the monopolar stimulation of 4 electrode contacts and the resulting effects on parkinsonian symptoms were evaluated.
METHODS: Seventeen consecutive patients (3 males and 14 females) were enrolled in the study. The patients were evaluated while in a nonmedicated state, and 10-20 min after switching on the pulse generator the effects of stimulation were assessed using separate-subset Unified Parkinson's Disease Rating Scale scores.
RESULTS: The relationship between the site stimulated and the percent improvement was analyzed using polynomial regression. Rigidity (p = 0.0004, R2 = 0.15), akinesia (p = 0.02, R2 = 0.07) and total score (p = 0.009, R2 = 0.089) well fit to second-order polynomial regression and showed the greatest improvement after stimulation at 0-1 mm below the horizontal anterior-posterior commissure (AC-PC) plane. Tremor (p = 0.24, R2 = 0.18) and gait (p = 0.36, R2 = 0.001) had a weak relation to the site stimulated, but stimulation at the sites 0-1 mm below the AC-PC plane also produced greater improvement than stimulation at more ventral or dorsal sites. The percent improvement of the posture (p = 0.92, R2 = 0.002) had no relation to the site stimulated. The dorsal border of the subthalamic nucleus was located 0.6 +/- 1.2 mm (n = 27) below the AC-PC plane and the most effective electrode contact 1.2 +/- 1.3 mm (n = 27) below it.
CONCLUSIONS: Stimulation around the dorsal border of the subthalamic nucleus, close to the AC-PC plane, produces greater improvement of parkinsonian symptoms than stimulation at more ventral or dorsal sites. Copyright 2006 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2006        PMID: 16905883     DOI: 10.1159/000094956

Source DB:  PubMed          Journal:  Stereotact Funct Neurosurg        ISSN: 1011-6125            Impact factor:   1.875


  7 in total

1.  Current steering to control the volume of tissue activated during deep brain stimulation.

Authors:  Christopher R Butson; Cameron C McIntyre
Journal:  Brain Stimul       Date:  2008-01       Impact factor: 8.955

2.  Deep brain stimulation activation volumes and their association with neurophysiological mapping and therapeutic outcomes.

Authors:  C B Maks; C R Butson; B L Walter; J L Vitek; C C McIntyre
Journal:  J Neurol Neurosurg Psychiatry       Date:  2008-04-10       Impact factor: 10.154

3.  Relative contributions of local cell and passing fiber activation and silencing to changes in thalamic fidelity during deep brain stimulation and lesioning: a computational modeling study.

Authors:  Rosa Q So; Alexander R Kent; Warren M Grill
Journal:  J Comput Neurosci       Date:  2011-10-05       Impact factor: 1.621

4.  Beta-coupled high-frequency activity and beta-locked neuronal spiking in the subthalamic nucleus of Parkinson's disease.

Authors:  Andrew I Yang; Nora Vanegas; Codrin Lungu; Kareem A Zaghloul
Journal:  J Neurosci       Date:  2014-09-17       Impact factor: 6.167

5.  Effects of subthalamic stimulation on speech of consecutive patients with Parkinson disease.

Authors:  E Tripoliti; L Zrinzo; I Martinez-Torres; E Frost; S Pinto; T Foltynie; E Holl; E Petersen; M Roughton; M I Hariz; P Limousin
Journal:  Neurology       Date:  2010-11-10       Impact factor: 9.910

6.  Ultra-high field magnetic resonance imaging of the basal ganglia and related structures.

Authors:  Birgit R Plantinga; Yasin Temel; Alard Roebroeck; Kâmil Uludağ; Dimo Ivanov; Mark L Kuijf; Bart M Ter Haar Romenij
Journal:  Front Hum Neurosci       Date:  2014-11-05       Impact factor: 3.169

7.  Phase-dependent modulation as a novel approach for therapeutic brain stimulation.

Authors:  Ramin Azodi-Avval; Alireza Gharabaghi
Journal:  Front Comput Neurosci       Date:  2015-02-26       Impact factor: 2.380

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.